Wyeth/King Altace Partnership Hits Rocky Patch; Mylan Bid Questioned
Executive Summary
A lawsuit filed by Wyeth alleging that King failed to meet its co-promotional obligations for Altace is the latest potential obstacle to Mylan in its bid to acquire King
You may also be interested in...
Mylan Fights For King; Plans Include Retention Bonuses For Employees
Mylan believes it is making progress in selling the proposed acquisition of King to investors
Mylan Places Big Bet On Antihypertensives: $4 Bil. Deal For King
Mylan's proposed acquisition of King is a big move by the generic company to carve out a leading position in the branded antihypertensive market
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011